189 related articles for article (PubMed ID: 25192287)
1. Potential therapeutic roles of tanshinone IIA in human bladder cancer cells.
Chiu SC; Huang SY; Chang SF; Chen SP; Chen CC; Lin TH; Liu HH; Tsai TH; Lee SS; Pang CY; Hsieh TF
Int J Mol Sci; 2014 Sep; 15(9):15622-37. PubMed ID: 25192287
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA induces apoptosis in human oral cancer KB cells through a mitochondria-dependent pathway.
Tseng PY; Lu WC; Hsieh MJ; Chien SY; Chen MK
Biomed Res Int; 2014; 2014():540516. PubMed ID: 24900970
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
4. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of tanshinone IIA and andrographolide on the apoptosis of cancer cells via crosstalk between p53 and reactive oxygen species pathways.
Li Y; Jiang B; Wang R; Wang J; Li Y; Bao Y
Pharmacol Rep; 2020 Apr; 72(2):400-417. PubMed ID: 32048269
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells.
Dai ZK; Qin JK; Huang JE; Luo Y; Xu Q; Zhao HL
J Nat Med; 2012 Jan; 66(1):192-201. PubMed ID: 21853384
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G
Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway.
Xie Z; He B; Jiang Z; Zhao L
J Recept Signal Transduct Res; 2020 Dec; 40(6):591-598. PubMed ID: 32496906
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway.
Liao XZ; Gao Y; Huang S; Chen ZZ; Sun LL; Liu JH; Chen HR; Yu L; Zhang JX; Lin LZ
Phytother Res; 2019 Sep; 33(9):2298-2309. PubMed ID: 31268205
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
Liu Z; Zhu W; Kong X; Chen X; Sun X; Zhang W; Zhang R
Oncol Rep; 2019 Nov; 42(5):1893-1903. PubMed ID: 31485631
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA reduces palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 liver cells.
Wang J; Hu R; Yin C; Xiao Y
Fundam Clin Pharmacol; 2020 Apr; 34(2):249-262. PubMed ID: 31520549
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H
Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling.
Feng F; Cheng P; Xu S; Li N; Wang H; Zhang Y; Wang W
Chem Biol Interact; 2020 Mar; 319():109024. PubMed ID: 32097614
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
17. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells.
Chiu SC; Chiu TL; Huang SY; Chang SF; Chen SP; Pang CY; Hsieh TF
BMC Complement Altern Med; 2017 Dec; 17(1):523. PubMed ID: 29207978
[TBL] [Abstract][Full Text] [Related]
19. The anticancer mechanism investigation of Tanshinone II
Cao YF; Wang SF; Li X; Zhang YL; Qiao YJ
BMC Syst Biol; 2018 Oct; 12(1):90. PubMed ID: 30373594
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]